Patients with COPD who are being prescribed inhaled corticosteroids have a 70% increased risk of being hospitalised for pneumonia, according to latest study findings.
Such patients also have a 53% increased relative risk of dying within 30 days of admission, research shows.
The figures come from a study of 175,906 patients with COPD in Canada, and follow secondary findings from another recently-published study on inhaled corticosteroids with a long-acting â-agonist.
Dr Mark Woodhead, consultant in general and respiratory medicine at Manchester Royal Infirmary, said: 'These observations cannot simply be dismissed.'
American Journal of Respiratory and Critical Care Medicine (2007) 176: 162-166